Identification of the calcitonin receptor in osteoarthritic chondrocytes

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Segovia Silvestre, Toni ^a   Bonnefond, Caroline ^a   Sondergaard, Bodil C ^a   Christensen, Tjorbjoern ^b   Karsdal, Morten A ^a   Bay Jensen, Anne C ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LACUNA;

EID: 80053925293     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-407     Document Type: Article

References (49)

1. Calcitonin inhibits phospholipase A2 and collagenase activity of human osteoarthritic chondrocytes. Hellio MP, Peschard MJ, Cohen C, Richard M, Vignon E, Osteoarthritis Cartilage 1997 5 2 121 8 10.1016/S1063-4584(97)80005-2 9135823 (Pubitemid 27141775)
2. Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. Sondergaard BC, Wulf H, Henriksen K, Schaller S, Oestergaard S, Qvist P, et al. Osteoarthritis Cartilage 2006 14 8 759 68 10.1016/j.joca.2006.01.014 16549372 (Pubitemid 43986356)
3. Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation. Karsdal MA, Sumer EU, Wulf H, Madsen SH, Christiansen C, Fosang AJ, et al. Arthritis Rheum 2007 56 1549 58 10.1002/art.22599 17469134 (Pubitemid 46764084)
4. Calcitonin and parathyroid-hormone stimulation of acid mucopolysaccharide synthesis in cultured chondrocytes isolated from growth cartilage. Suzuki F, Yoneda T, Shimomura Y, FEBS Lett 1976 70 1 155 8 10.1016/0014-5793(76)80747-8 136366
5. A serum-free medium supplemented with multiplication-stimulating activity (MSA) supports both proliferation and differentiation of chondrocytes in primary culture. Kato Y, Nasu N, Takase T, Daikuhara Y, Suzuki F, Exp Cell Res 1980 125 1 167 74 10.1016/0014-4827(80)90200-1 6444284 (Pubitemid 10140126)
6. Calcitonin stimulates growth and maturation of embryonic chick pelvic cartilage in vitro. Burch WM, Endocrinology 1984 114 4 1196 202 10.1210/endo-114-4-1196 6705735 (Pubitemid 14134365)
7. Effects of human and salmon calcitonin on human articular chondrocytes cultivated in clusters. Franchimont P, Bassleer C, Henrotin Y, Gysen P, Bassleer R, J Clin Endocrinol Metab 1989 69 2 259 66 10.1210/jcem-69-2-259 2753973 (Pubitemid 19208447)
8. Morphometric changes in the epiphyseal plate of the growing and young adult male rat after long-term salmon calcitonin administration. Khaldi L, Karachalios T, Galanos A, Lyritis GP, Calcif Tissue Int 2005 76 6 426 32 10.1007/s00223-004-1041-9 15895285 (Pubitemid 41185870)
9. Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency. Behets C, Williams JM, Chappard D, Devogelaer JP, Manicourt DH, J Bone Miner Res 2004 19 11 1821 6 10.1359/JBMR.040609 15476582 (Pubitemid 41103433)
10. Treatment with calcitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis. El Hajjaji H, Williams JM, Devogelaer JP, Lenz ME, Thonar EJ, Manicourt DH, Osteoarthritis Cartilage 2004 12 11 904 11 10.1016/j.joca.2004.08.005 15501406 (Pubitemid 39462605)
11. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions. Manicourt DH, Altman RD, Williams JM, Devogelaer JP, Druetz-Van Egeren A, Lenz ME, et al. Arthritis Rheum 1999 42 6 1159 67 10.1002/1529-0131(199906)42:6<1159::AID- ANR12>3.0.CO;2-Q 10366108 (Pubitemid 29268952)
12. Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover. Nielsen RH, Bay-Jensen AC, Byrjalsen I, Karsdal MA, Osteoarthritis Cartilage 2011 19 4 466 73 10.1016/j.joca.2011.01.008 21251986
13. Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Manicourt DH, Azria M, Mindeholm L, Thonar EJ, Devogelaer JP, Arthritis Rheum 2006 54 10 3205 11 10.1002/art.22075 17009253 (Pubitemid 44622091)
14. The long-term predictive value of bone mineral density measurements for fracture risk is independent of the site of measurement and the age at diagnosis: results from the Prospective Epidemiological Risk Factors study. Bagger YZ, Tanko LB, Alexandersen P, Hansen HB, Qin G, Christiansen C, Osteoporos Int 2006 17 3 471 7 10.1007/s00198-005-0009-6 16261280
15. Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Lin HY, Harris TL, Flannery MS, Aruffo A, Kaji EH, Gorn A, et al. Science 1991 254 5034 1022 4 10.1126/science.1658940 1658940 (Pubitemid 21917435)
16. Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. Gorn AH, Lin HY, Yamin M, Auron PE, Flannery MR, Tapp DR, et al. J Clin Invest 1992 90 5 1726 35 10.1172/JCI116046 1331173
17. Molecular cloning and characterization of the porcine calcitonin gene-related peptide receptor. Elshourbagy NA, Adamou JE, Swift AM, Disa J, Mao J, Ganguly S, et al. Endocrinology 1998 139 4 1678 83 10.1210/en.139.4.1678 9528949 (Pubitemid 28513824)
18. A novel calcitonin receptor gene in human osteoclasts from normal bone marrow. Nishikawa T, Ishikawa H, Yamamoto S, Koshihara Y, FEBS Lett 1999 458 3 409 14 10.1016/S0014-5793(99)01176-X 10570950 (Pubitemid 29433845)
19. Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript. Moore EE, Kuestner RE, Stroop SD, Grant FJ, Matthewes SL, Brady CL, et al. Mol Endocrinol 1995 9 8 959 68 10.1210/me.9.8.959 7476993
20. A new type of human calcitonin receptor isoform generated by alternative splicing. Nakamura M, Hashimoto T, Nakajima T, Ichii S, Furuyama J, Ishihara Y, et al. Biochem Biophys Res Commun 1995 209 2 744 51 10.1006/bbrc.1995.1562 7733946
21. The human calcitonin receptor gene (CALCR) at 7q21.3 is outside the deletion associated with the Williams syndrome. Perez Jurado LA, Li X, Francke U, Cytogenet Cell Genet 1995 70 3-4 246 9 10.1159/000134044 7789182
22. Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. Gorn AH, Lin HY, Yamin M, Auron PE, Flannery MR, Tapp DR, et al. J Clin Invest 1992 90 5 1726 35 10.1172/JCI116046 1331173
23. Cloning and characterization of an abundant subtype of the human calcitonin receptor. Kuestner RE, Elrod RD, Grant FJ, Hagen FS, Kuijper JL, Matthewes SL, et al. Mol Pharmacol 1994 46 2 246 55 8078488 (Pubitemid 24271420)
24. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. Expression and mutational analysis of synthetic receptor genes. Nussenzveig DR, Thaw CN, Gershengorn MC, J Biol Chem 1994 269 45 28123 9 7961748
25. Differential effects of the 3',5'-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin. Su Y, Chakraborty M, Nathanson MH, Baron R, Endocrinology 1992 131 3 1497 502 10.1210/en.131.3.1497 1324163
26. Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin. Albrandt K, Mull E, Brady EM, Herich J, Moore CX, Beaumont K, FEBS Lett 1993 325 3 225 32 10.1016/0014-5793(93)81078-E 8391477 (Pubitemid 23186482)
27. Molecular characterization of two novel isoforms of the human calcitonin receptor. Beaudreuil J, Balasubramanian S, Chenais J, Taboulet J, Frenkian M, Orcel P, et al. Gene 2004 343 1 143 51 10.1016/j.gene.2004.08.019 15563840 (Pubitemid 39551038)
28. In vitro characterization of a human calcitonin receptor gene polymorphism. Wolfe LA III, Fling ME, Xue Z, Armour S, Kerner SA, Way J, et al. Mutat Res 2003 522 1-2 93 105 10.1016/S0027-5107(02)00282-8 12517415 (Pubitemid 36216303)
29. A new type of human calcitonin receptor isoform generated by alternative splicing. Nakamura M, Hashimoto T, Nakajima T, Ichii S, Furuyama J, Ishihara Y, et al. Biochem Biophys Res Commun 1995 209 2 744 51 10.1006/bbrc.1995.1562 7733946
30. Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women. Masi L, Becherini L, Gennari L, Colli E, Mansani R, Falchetti A, et al. Biochem Biophys Res Commun 1998 245 2 622 6 10.1006/bbrc.1998.8445 9571205 (Pubitemid 28418555)
31. Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn FA, Martin TJ, J Clin Invest 1986 78 2 355 60 10.1172/JCI112584 3016026 (Pubitemid 16074070)
32. Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. Sondergaard BC, Wulf H, Henriksen K, Schaller S, Oestergaard S, Qvist P, et al. Osteoarthritis Cartilage 2006 14 8 759 68 10.1016/j.joca.2006.01.014 16549372 (Pubitemid 43986356)
33. Evidence that human cartilage and chondrocytes do not express calcitonin receptor. Lin Z, Pavlos NJ, Cake MA, Wood DJ, Xu J, Zheng MH, Osteoarthritis Cartilage 2008 16 4 450 7 10.1016/j.joca.2007.08.003 17890110 (Pubitemid 351426270)
34. Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. Sorensen MG, Henriksen K, Schaller S, Henriksen DB, Nielsen FC, Dziegiel MH, et al. J Bone Miner Metab 2007 25 1 36 45 17187192 (Pubitemid 46012995)
35. In vitro characterization of a human calcitonin receptor gene polymorphism. Wolfe LA III, Fling ME, Xue Z, Armour S, Kerner SA, Way J, et al. Mutat Res 2003 522 1-2 93 105 10.1016/S0027-5107(02)00282-8 12517415 (Pubitemid 36216303)
36. Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women. Taboulet J, Frenkian M, Frendo JL, Feingold N, Jullienne A, de Vernejoul MC, Hum Mol Genet 1998 7 13 2129 33 10.1093/hmg/7.13.2129 9817931 (Pubitemid 28546423)
37. Calcitonin receptor gene polymorphism in japanese women: correlation with body mass and bone mineral density. Nakamura M, Morimoto S, Zhang Z, Utsunomiya H, Inagami T, Ogihara T, et al. Calcif Tissue Int 2001 68 4 211 5 10.1007/s002230001215 11353946 (Pubitemid 32423105)
38. Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women. Masi L, Becherini L, Gennari L, Colli E, Mansani R, Falchetti A, et al. Biochem Biophys Res Commun 1998 245 2 622 6 10.1006/bbrc.1998.8445 9571205 (Pubitemid 28418555)
39. Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women. Taboulet J, Frenkian M, Frendo JL, Feingold N, Jullienne A, de Vernejoul MC, Hum Mol Genet 1998 7 13 2129 33 10.1093/hmg/7.13.2129 9817931 (Pubitemid 28546423)
40. [Genetic polymorphism of the calcitonin receptor gene and bone mineral density in Polish population of postmenopausal women]. Drews K, Seremak-Mrozikiewicz A, Bartkowiak-Wieczorek J, Pienkowski W, Dubiel M, Mrozikiewicz PM, Ginekol Pol 2005 76 8 612 8 16363366
41. In vitro characterization of a human calcitonin receptor gene polymorphism. Wolfe LA III, Fling ME, Xue Z, Armour S, Kerner SA, Way J, et al. Mutat Res 2003 522 1-2 93 105 10.1016/S0027-5107(02)00282-8 12517415 (Pubitemid 36216303)
42. Association of the calcitonin gene (CA) polymorphism with osteoarthritis of the knee in a Mexican mestizo population. Magana JJ, Galvez-Rosas A, Gonzalez-Huerta C, Duarte-Salazar C, Lara-Alvarado L, Soria-Bastida MA, et al. Knee 2010 17 2 157 60 10.1016/j.knee.2009.08.006 19736013
43. Glycosylation is important for binding to human calcitonin receptors. Ho HH, Gilbert MT, Nussenzveig DR, Gershengorn MC, Biochemistry 1999 38 6 1866 72 10.1021/bi981195e 10026267 (Pubitemid 29085336)
44. Evidence that human cartilage and chondrocytes do not express calcitonin receptor. Lin Z, Pavlos NJ, Cake MA, Wood DJ, Xu J, Zheng MH, Osteoarthritis Cartilage 2008 16 4 450 7 10.1016/j.joca.2007.08.003 17890110 (Pubitemid 351426270)
45. Evidence that human cartilage and chondrocytes do not express calcitonin receptor. Lin Z, Pavlos NJ, Cake MA, Wood DJ, Xu J, Zheng MH, Osteoarthritis Cartilage 2008 16 4 450 7 10.1016/j.joca.2007.08.003 17890110 (Pubitemid 351426270)
46. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Benya PD, Padilla SR, Nimni ME, Cell 1978 15 4 1313 21 10.1016/0092-8674(78)90056-9 729001 (Pubitemid 9109690)
47. Expression of mRNAs for collagens and other matrix components in dedifferentiating and redifferentiating human chondrocytes in culture. Elima K, Vuorio E, FEBS Lett 1989 258 2 195 8 10.1016/0014-5793(89)81651-5 2599085 (Pubitemid 20001046)
48. Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors. Stokes DG, Liu G, Dharmavaram R, Hawkins D, Piera-Velazquez S, Jimenez SA, Biochem J 2001 360 Pt 2 461 70 11716775 (Pubitemid 33151341)
49. Should subchondral bone turnover be targeted when treating osteoarthritis? Karsdal MA, Leeming DJ, Dam EB, Henriksen K, Alexandersen P, Pastoureau P, et al. Osteoarthritis Cartilage 2008 16 6 638 46 10.1016/j.joca.2008.01.014 18362080